Glenmark Pharmaceuticals P/B Ratio
Glenmark Pharmaceuticals (GLENMARK) P/B ratio is 6.49 (High), book value per share ₹3754.29 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Glenmark Pharmaceuticals stock price NSE.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
GLENMARK P/B Ratio — Valuation Insights & Book Value Analysis
Glenmark Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 6.49 (High). Read GLENMARK dividend growth for the complete payout history and dividend yield track record.
- Stock appears overvalued with PB of 6.49, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1355.2% above historical average
- Trading at premium to sector average PB of -0.01
Glenmark Pharmaceuticals P/B Ratio Historical Trend
GLENMARK annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore GLENMARK investment value to estimate fundamental worth using multiple valuation models.
GLENMARK Historical P/B Ratio — Book Value Per Share & Year-End Price
Glenmark Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.65 | ₹3754.29 | ₹2447.40 | ₹10,512 | Low |
| 2025 | 0.64 | ₹3160.36 | ₹2035.20 | ₹8,849 | Low |
| 2024 | 0.57 | ₹2802.86 | ₹1609.10 | ₹7,848 | Low |
| 2023 | 0.24 | ₹3513.93 | ₹853.95 | ₹9,839 | Low |
| 2022 | 0.13 | ₹3370.71 | ₹424.15 | ₹9,438 | Low |
GLENMARK vs Healthcare Peers — P/B Ratio Comparison
Glenmark Pharmaceuticals P/B 6.49 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |